Article
Cystic fibrosis: candidate selection and impact of the cystic fibrosis transmembrane conductance regulator therapy.
Current opinion in organ transplantation - 1 Jun 2022
Lehr Carli J, Pilewski Joseph M
Abstract excerpt
PURPOSE OF REVIEW: Over the past decade, the development of highly effective cystic fibrosis (CF) transmembrane conductance regulator (CFTR) modulators has dramatically ameliorated the manifestations of CF for most patients. Perhaps most importantly, CFTR modulators impact the development and progression of advanced lung disease (ALD) and are changing the CF population accessing lung transplant. RECENT FINDINGS:...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.